500mg Diosmin Tablet with GMP

Product Details
Customization: Available
Application: Internal Medicine
Usage Mode: For oral administration
Still deciding? Get samples of US$ 0/Piece
Request Sample
Manufacturer/Factory, Trading Company

360° Virtual Tour

Diamond Member Since 2015

Suppliers with verified business licenses

Audited Supplier

Audited by an independent third-party inspection agency

Years of Export Experience
The export experience of the supplier is more than 10 years
High Repeat Buyers Choice
More than 50% of buyers repeatedly choose the supplier
Importers and Exporters
The supplier has import and export rights
Management Certification
The supplier has quality management system certification, including:
ISO9001:2015 certificate
ISO45001:2018 certificate
ISO14001
to see all verified strength labels (20)
  • 500mg Diosmin Tablet with GMP
  • 500mg Diosmin Tablet with GMP
  • 500mg Diosmin Tablet with GMP
Find Similar Products

Basic Info.

Model NO.
AMC12122
Suitable for
Adult
State
Solid
Shape
Tablet
Type
Biological Products
Pharmaceutical Technology
Chemical Synthesis
Registration
Available
OEM
Available
Transport Package
10tabs/Blister*3blister/Box
Specification
500mg
Trademark
MEDIPHARM /SHINEPHARM
Origin
China
HS Code
3004909099
Production Capacity
500000 Boxes/Month

Product Description

 

500mg Diosmin Tablet with GMP

Use:
Diosmin has been widely used since 1969 as a phlebotonic and vascular protector for venous leg ulcers and hemorrhoids; however, clinical data to support these uses are limited. Most, but not all available clinical data support its use for chronic venous insufficiency (CVI) and hemorrhoid disease, both acute and chronic. Diosmin has also been used to improve postoperative cardiac function and outcomes in adults undergoing coronary artery bypass grafting (CABG) surgery, for pelvic congestion caused by pelvic varicose veins in men and women, and for varicoceles in men; however, few large-scale quality clinical trials support these uses.
Pregnancy/Lactation:
Avoid use. Diosmin is not recommended for use in pregnant or breast-feeding women.
Interactions:
Serum concentrations may be increased by coadministration of drugs metabolized by cytochrome P450 (CYP-450) 2E1 or 2C9, or by P-glycoprotein.
Adverse Reactions:
The most common adverse effects are mild GI and autonomic disturbances (pruritus, erythema, dermatitis [hives, itching], stomach and epigastric pain, nausea, diarrhea, and dizziness); cardiac arrhythmias (tachycardia) and hemolytic anemia have also been documented. Rare excessive peripheral vasoconstriction and ischemic damage have been reported.
Toxicology:
Extensive safety evaluations conducted with MPFF found no risk of toxicity500mg Diosmin Tablet with GMP500mg Diosmin Tablet with GMP

500mg Diosmin Tablet with GMP500mg Diosmin Tablet with GMP500mg Diosmin Tablet with GMP500mg Diosmin Tablet with GMP

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier